Cardiovascular Systems, Inc.'s 12-Month Data from COMPLIANCE 360° Study of Above-the-Knee Peripheral Arterial Disease Presented at American College of Cardiology

ST. PAUL, Minn. & CHICAGO--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), today presented 12-month data from the COMPLIANCE 360° study of severely calcified above-the-knee lesions at the American College of Cardiology’s (ACC) 61st Annual Scientific Session. Dr. Raymond Dattilo, St. Francis Health Center, Topeka, Kan., principal investigator of the study, presented the long-term data (Abstract Presentation #1123-37) demonstrating that strong acute results translate into positive clinical outcomes at 12 months.

MORE ON THIS TOPIC